Search research articles
Contact Us
Filters
Showing results (1-10 of 274) with videos related to
Page
of 28
Sort By:
Continuum (Minneapolis, Minn.)
|
December 2, 2024
Diagnosing Alzheimer Disease
Gregory S Day
Continuum (Minneapolis, Minn.)
|
June 9, 2022
Rapidly Progressive Dementia
Gregory S Day
Continuum (Minneapolis, Minn.)
|
February 2, 2019
Reversible Dementias
Gregory S Day
JAMA Neurology
|
November 29, 2016
Rethinking Outcomes in Leucine-Rich, Glioma-Inactivated 1 Protein Encephalitis: "Good" Isn't Good Enough
Gregory S Day
Molecular Neurodegeneration
|
September 24, 2021
Measuring the cognitive costs of the COVID-19 pandemic
Gregory S Day
Current Opinion in Neurology
|
February 1, 2022
Deciphering the contributions of neuroinflammation to neurodegeneration: lessons from antibody-mediated encephalitis and coronavirus disease 2019
Dror Shir, Gregory S Day
Current Opinion in Neurology
|
June 8, 2022
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients
Pierpaolo Turcano, Gregory S Day
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
June 13, 2015
Fanning the Flames in Anti-N-methyl-D-aspartate Receptor Encephalitis
Gregory S Day, David G Munoz
Molecular Neurodegeneration
|
June 28, 2023
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
Vijay K Ramanan, Gregory S Day
Current Neurology and Neuroscience Reports
|
June 12, 2020
Sleep Disturbances in Patients with Autoimmune Encephalitis
Margaret S Blattner, Gregory S Day
Page
of 28
Search research articles
Search
Showing results (1-10 of 274) with videos related to
Sort By:
Page
of 28
Continuum (Minneapolis, Minn.)
|
December 2, 2024
Diagnosing Alzheimer Disease
Gregory S Day
Continuum (Minneapolis, Minn.)
|
June 9, 2022
Rapidly Progressive Dementia
Gregory S Day
Continuum (Minneapolis, Minn.)
|
February 2, 2019
Reversible Dementias
Gregory S Day
JAMA Neurology
|
November 29, 2016
Rethinking Outcomes in Leucine-Rich, Glioma-Inactivated 1 Protein Encephalitis: "Good" Isn't Good Enough
Gregory S Day
Molecular Neurodegeneration
|
September 24, 2021
Measuring the cognitive costs of the COVID-19 pandemic
Gregory S Day
Current Opinion in Neurology
|
February 1, 2022
Deciphering the contributions of neuroinflammation to neurodegeneration: lessons from antibody-mediated encephalitis and coronavirus disease 2019
Dror Shir, Gregory S Day
Current Opinion in Neurology
|
June 8, 2022
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients
Pierpaolo Turcano, Gregory S Day
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
June 13, 2015
Fanning the Flames in Anti-N-methyl-D-aspartate Receptor Encephalitis
Gregory S Day, David G Munoz
Molecular Neurodegeneration
|
June 28, 2023
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
Vijay K Ramanan, Gregory S Day
Current Neurology and Neuroscience Reports
|
June 12, 2020
Sleep Disturbances in Patients with Autoimmune Encephalitis
Margaret S Blattner, Gregory S Day
Page
of 28